WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the release of reports exposing the drug industry’s disinformation campaign attacking the 340B Drug Pricing Program. Ryan White Clinics for 340B Access last week published a rebuttal against the plethora of so-called ‘studies’ whose authors have financial ties to the drug industry. Ryan White Clinics for 340B Access (https://rwc340b.org/), … [Read more…]
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared to the one-year and two-year study results DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the journal of … [Read more…]
Automation – AI-assisted Automatic Assessment and Automated Notifications enable doctors to prioritize treatment tracking exceptions to address treatment progress including patient compliance, key for teens and their parents Integration – Creates a seamless and intelligent, single-platform experience for doctors and their staff through integration with the Invisalign Doctor Site TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#ESG–Sabra Health Care REIT, Inc. (“Sabra,” or “we”) (Nasdaq: SBRA) today released its second annual Sustainability Report. The report highlights Sabra’s priorities and initiatives on environmental stewardship, social commitment, corporate governance and community service. “We endeavor to operate efficiently, sustainably and in the best interest of our stakeholders,” said Rick Matros, Sabra’s Chair, … [Read more…]
Dr. Sans brings over two decades of life sciences experience spanning investment banking, corporate development, and clinical research LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is pioneering allogeneic cell-based platforms to revolutionize oncolytic virus therapies, today announced the appointment of David Sans, FAARM, Ph.D, MBA, in New York as Head … [Read more…]
Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023 SACRAMENTO, Calif.–(BUSINESS WIRE)–The Cancer Care Is Different (CCID) Coalition today commends Gov. Gavin Newsom for signing the California Cancer Care Equity Act (SB 987), a bill that will expand access to … [Read more…]
– Company on track to commence enrollment and dosing of Phase 2 study of Trappsol® Cyclo™ for the treatment of Alzheimer’s disease before year end – Ongoing advancement of global pivotal study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (NPC1) – Company to participate at the 2022 NPUK Annual Family Conference & Interactive … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Biostorage Service Market, Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report focuses on Biostorage Service market revenue at the global, regional, and company level. From a global perspective, this report represents overall Biostorage Service market size by analyzing historical data and future prospect. Key Points Covered in the … [Read more…]
Recently rebranded careviso is scaling its technology and offerings to remove the administrative barriers associated with prior authorizations and financial transparency for diagnostic testing Technology provides enhanced outcomes and transparency for patients and physicians alike FALLS CHURCH, Va.–(BUSINESS WIRE)–careviso, a healthcare technology company and market leader in molecular diagnostic patient access technology (the “Company”), today … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering. The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD … [Read more…]
